MoneyWorks4Me

Supriya Lifescience - Quaterly Results

07 Nov 2023 Evaluate
The Revenue for the quarter ended  September 2023 of Rs. 1400.95 millions grew by 24.89 % from Rs. 1121.72 millions.A comparatively good net profit growth of 41.64% to Rs. 238.84 millions was reported for the quarter ended September 2023 compared to Rs. 168.62 millions of previous same quarter.Operating profit surged to 342.19 millions from the corresponding previous quarter of 311.67 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1400.95 1121.72 24.89 2721.16 2135.27 27.44 4609.38 5300.49 -13.04
Other Income 24.67 26.05 -5.30 53.85 49.62 8.52 94.89 75.77 25.23
PBIDT 342.19 311.67 9.79 816.28 647.70 26.03 1383.87 2215.62 -37.54
Interest 4.60 7.75 -40.65 12.76 13.56 -5.90 30.84 41.98 -26.54
PBDT 337.59 303.92 11.08 803.52 634.14 26.71 1353.03 2173.64 -37.75
Depreciation 39.81 29.73 33.91 79.36 58.58 35.47 118.15 101.18 16.77
PBT 297.78 274.19 8.60 724.16 575.56 25.82 1234.88 2072.46 -40.41
TAX 58.94 105.57 -44.17 200.20 154.44 29.63 336.30 554.35 -39.33
Deferred Tax -26.44 0.91 -3005.49 15.19 3.91 288.49 29.49 32.46 -9.15
PAT 238.84 168.62 41.64 523.96 421.12 24.42 898.58 1518.11 -40.81
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 24.43 27.79 -12.09 30.00 30.33 -1.11 30.02 41.80 -28.18
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..